FDA Inspection 1076828 — Accriva Diagnostics, Inc.

Accriva Diagnostics, Inc. — FEI 2250033

The FDA completed an inspection of Accriva Diagnostics, Inc. on January 18, 2019 in San Diego, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 18, 2019
Fiscal Year
2019
Product Type
Devices
Project Area
Compliance: Devices
Location
San Diego, CA (United States)

Citations

IDCFRDescription
1471621 CFR 820.30(f)Design verification - output does not meet input requirement
255721 CFR 820.30(c)Design input - documentation
312521 CFR 820.80(d)Lack of or inadequate final acceptance procedures
317221 CFR 820.198(c)Investigation of device failures
54621 CFR 820.75(a)Lack of or inadequate process validation